In outpatients with mild to moderate COVID-19, low-dose fluvoxamine did not reduce time to sustained recovery
Description
McCarthy MW, Naggie S, Boulware DR, et al. Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial. JAMA. 2023;329:296-305. 36633838.
